Skip to main navigation
Skip to search
Skip to main content
PolyU Scholars Hub Home
Help & FAQ
Link opens in a new tab
Search content at PolyU Scholars Hub
Home
Researchers
Units
Research output
Prizes
Activities
Press/Media
Student theses
Mycoplasma pneumoniae infections: Pathogenesis and vaccine development
Zhulin Jiang
, Shuihong Li
, Cuiming Zhu
, Runjie Zhou
,
Polly H.M. Leung
Department of Health Technology and Informatics
The Hong Kong Polytechnic University
Research output
:
Journal article publication
›
Review article
›
Academic research
›
peer-review
149
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Mycoplasma pneumoniae infections: Pathogenesis and vaccine development'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Infection
100%
Vaccine Development
100%
Host Cell
100%
Protein P30
100%
Mycoplasma Pneumonia
100%
Side Effect
50%
Serositis
50%
Virulence Factor
50%
Quinolone Derivative
50%
Respiratory Tract Inflammation
50%
Reinfection
50%
Immune Injury
50%
Subunit Vaccine
50%
Community-Acquired Pneumonia
50%
Lower Respiratory Tract
50%
Upper Respiratory Tract
50%
Immune Evasion
50%
Pathogen
50%
Antibiotics
50%
Cytotoxicity
50%
Macrolide
50%
Live Vaccine
50%
DNA Immunization
50%
Cell Vaccine
50%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccine Development
100%
Infection
100%
Protein P30
100%
Mycoplasma Pneumonia
100%
Macrolide
50%
Infectious Agent
50%
Antibiotics
50%
Live Vaccine
50%
Tetracycline Derivative
50%
Community Acquired Pneumonia
50%
Side Effect
50%
Syndrome
50%
Virulence Factor
50%
Reinfection
50%
Quinolone Derivative
50%
Respiratory Tract Inflammation
50%
Immune Injury
50%
Subunit Vaccine
50%
Inflammation
50%
Cytotoxicity
50%
DNA Immunization
50%
Cell Vaccine
50%
Immunology and Microbiology
Host Cell
100%
Mycoplasma pneumoniae
100%
Inactivated Vaccine
50%
Attenuated Vaccine
50%
Inflammation Response
50%
Infectious Agent
50%
Cytotoxicity
50%
Virulence Factor
50%
Whole Cell
50%
Upper Respiratory Tract
50%
Immune Evasion
50%
Lower Respiratory Tract
50%
Immune Injury
50%
Live Vaccine
50%
Subunit Vaccine
50%
DNA Immunization
50%
Keyphrases
Vaccine Development
100%
Mycoplasma Pneumoniae (M. pneumoniae)
100%
Host Cell
25%
Pathogenic Mechanism
25%
Pneumonia Infection
25%
Adhesion
12%
Rate of Increase
12%
Inflammation
12%
Young children
12%
Health Risk
12%
Infection Risk
12%
Resistant Strains
12%
Tetracycline
12%
Virulence Factors
12%
Antibiotics
12%
Inflammatory Response
12%
Causative Agents
12%
Immune Evasion
12%
Life-threatening
12%
Narrative Review
12%
Difficult-to-treat
12%
Whole-cell Vaccine
12%
Reinfection
12%
Lower Respiratory Tract
12%
Upper Respiratory Tract
12%
Macrolide Resistance
12%
Pneumococcal Vaccine
12%
Infections in children
12%
P30 Protein
12%
Live Attenuated Vaccine
12%
Community-acquired Pneumonia
12%
Direct Cytotoxicity
12%
DNA Vaccine
12%
Subunit Vaccine
12%
CARDS Toxin
12%
Refractory Pneumonia
12%
Respiratory Quinone
12%
P1 Protein
12%
Immune Injury
12%